Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Melanoma associated antigen (MAGE)-A3 expression in Stages I and II non-small cell lung cancer: results of a multi-center study

Published:2004-01 Issue:1 Volume:25 Page:131-134
ISSN:1010-7940
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:European Journal of Cardio-Thoracic Surgery

Author:

Sienel W.,Varwerk C.,Linder A.,Kaiser D.,Teschner M.,Delire M.,Stamatis G.,Passlick B.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/25/1/131/1011194/25-1-131.pdf

Reference20 articles.

1. Incidence of local recurrence and second primary tumors in resected Stage I lung cancer;Martini;J Thorac Cardiovasc Surg,1995

2. Revisions in the international system for staging lung cancer;Mountain;Chest,1997

3. The development of immunotherapies for non-small cell lung cancer;Salgaller;Expert Opin Biol Ther,2002

4. Overview of therapeutic vaccination approaches for cancer;Berinstein;Semin Oncol,2003

5. Progress in human tumour immunology and immunotherapy;Rosenberg;Nature,2001

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The current therapeutic cancer vaccines landscape in non‐small cell lung cancer;International Journal of Cancer;2024-08-07

2. Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances;Life Sciences;2024-06

3. Recent advances in neoantigen vaccines for treating non‐small cell lung cancer;Thoracic Cancer;2023-10-31

4. Early-Stage Lung Cancer in the Era of Precision Oncology: From Immunotherapy to Targeted Therapy;Interventional Oncology;2023

5. An in silico reverse vaccinology approach to design a novel multiepitope peptide vaccine for non-small cell lung cancers;Informatics in Medicine Unlocked;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3